Clearbridge Investments
Clearbridge All Cap Growth Strategy
Growth
Dec 2024 → Mar 2025
Our archive holds 2 letters from this strategy, behind 3 investment theses and positions in 19 companies. Every quote below is copied verbatim from the letter it came from.
2 letters in 2 years · follow all of Clearbridge Investments for every strategy.
What it bought and sold
We closed out of AbbVie, in the health care sector, a biopharmaceutical company developing treatments for autoimmune diseases and cancer.
Charles River Laboratories, a provider of drug discovery services in the health care sector, was sold due to continued weakness among its large cap pharmaceutical customers as well as rhetoric from the Trump administration about cuts at the National Institutes of Health as well as volatile biotech funding trends.
Also held
Its investment theses
- AppLovinMar 2025AppLovin is the leading mobile game and app advertising platform with strong growth potential in both mobile marketing and e-commerce advertising, poised for significant free cash flow growth as the market recovers.
- Ares ManagementMar 2025Ares Management is a leading alternative asset manager in private credit, poised to benefit from market trends while maintaining a balance sheet light strategy and strong performance in downturns.
- Chipotle Mexican GrillDec 2024Chipotle Mexican Grill is an attractive investment opportunity due to its strong unit economics, growth plans to double its store footprint, and potential for margin expansion through technological enhancements.